SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : The Stock for 1999(Polymedica)PLMD(Medical Supply Co.)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Sam who wrote (2046)10/25/1998 12:54:00 PM
From: Arthur Radley  Read Replies (2) of 3414
 
For those that don't think that PM is being fairly valued in the market place, here is some supporting data I got today from Equity Digest/Market Guide through Charles Schwab. This was updated as of 10/24/98.
The first number is PM, the second is Industry Average and third is S&P500.

Price to Cash Flow: 5.8X 13.3X 21.2X
Price to Sales: 1.0X 9.3X 3.7X
Price to Book: 1.6X 6.5X 7.5X
EPS.5Yr.Growth: 116.6% 21.&% 19.3%
Revenue 5 Yr Growth: 46.3% 28.0% 13.8%
Profit Margin-5Yr.: 8.1% (4.4%) 10.2%
ROE.5 Yr. Av.: 7.3% (4.3%) 21.7%

Just think what PM stock price would be if they were valued the same as their peer companies or the S&P companies. Oh,Well!

This report also shows PM earning .15 cents this quarter.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext